87 related articles for article (PubMed ID: 8765669)
41. PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat.
Gracey DJ; Bell R; King DJ
Pharmacol Biochem Behav; 2000 Mar; 65(3):459-63. PubMed ID: 10683486
[TBL] [Abstract][Full Text] [Related]
42. Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells.
Bestervelt L; Barr B; Dethloff L
Cell Signal; 2000 Jan; 12(1):53-61. PubMed ID: 10676848
[TBL] [Abstract][Full Text] [Related]
43. Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.
Bellier B; Da Nascimento S; Meudal H; Gincel E; Roques BP; Garbay C
Bioorg Med Chem Lett; 1998 Jun; 8(11):1419-24. PubMed ID: 9871777
[TBL] [Abstract][Full Text] [Related]
44. Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E
Farmaco; 1996 May; 51(5):333-9. PubMed ID: 8767843
[TBL] [Abstract][Full Text] [Related]
45. Effects of two newly synthetized cholecystokinin tetrapeptides on the activity of single hippocampal and thalamic neurons.
Zippel U; Henklein P
Neuropeptides; 1995 Aug; 29(2):83-7. PubMed ID: 7477765
[TBL] [Abstract][Full Text] [Related]
46. beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists.
Martín-Martínez M; De La Figuera N; Latorre M; Herranz R; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
J Med Chem; 2000 Oct; 43(20):3770-7. PubMed ID: 11020292
[TBL] [Abstract][Full Text] [Related]
47. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
Singh L; Field MJ; Vass CA; Hughes J; Woodruff GN
Br J Pharmacol; 1992 Jan; 105(1):8-10. PubMed ID: 1350747
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of food intake by omeprazole in the chicken.
Campbell BJ; Dimaline R; Dockray GJ; Hughes J
Eur J Pharmacol; 1991 Dec; 209(3):231-5. PubMed ID: 1797564
[TBL] [Abstract][Full Text] [Related]
49. The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
Xu XJ; Hökfelt T; Hughes J; Wiesenfeld-Hallin Z
Neuroreport; 1994 Feb; 5(6):718-20. PubMed ID: 8199346
[TBL] [Abstract][Full Text] [Related]
50. The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.
Gouldson P; Legoux P; Carillon C; Delpech B; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 2000 Jul; 400(2-3):185-94. PubMed ID: 10988332
[TBL] [Abstract][Full Text] [Related]
51. Cholecystokinin and morphine analgesia: variations on a theme.
Stanfa L; Dickenson A; Xu XJ; Wiesenfeld-Hallin Z
Trends Pharmacol Sci; 1994 Mar; 15(3):65-6. PubMed ID: 8184487
[No Abstract] [Full Text] [Related]
52. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position.
Bartolomé-Nebreda JM; Patiño-Molina R; Martín-Martínez M; Gómez-Monterrey I; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
J Med Chem; 2001 Jun; 44(13):2219-28. PubMed ID: 11405658
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of 1,5-benzodiazepines with bridged cycloalkyl substituents at the N-1 position as potent and selective CCK-B Ligands.
Finizia G; Donati D; Pentassuglia G; Polinelli S; Tarzia G; Tranquillini ME; Ursini A
Arch Pharm (Weinheim); 1998 Jan; 331(1):41-4. PubMed ID: 9507701
[TBL] [Abstract][Full Text] [Related]
54. Aqueous stability and solubility of CI-988, a novel "dipeptoid" cholecystokinin-B receptor antagonist.
Kearney AS; Mehta SC; Radebaugh GW
Pharm Res; 1992 Aug; 9(8):1092-5. PubMed ID: 1409383
[TBL] [Abstract][Full Text] [Related]
55. 2-Carbethoxyindole derivatives. II. Synthesis of 8-benzyloxy-3H-pirydazino(4,5-b)indole-4-one.
Nantka-Namirski P; Ozdowska Z
Acta Pol Pharm; 1972; 29(1):16-9. PubMed ID: 4403423
[No Abstract] [Full Text] [Related]
56. Synthesis of new anthranilic acid dimer derivatives and their evaluation on CCK receptors.
Varnavas A; Lassiani L; Valenta V
Farmaco; 2000 May; 55(5):369-75. PubMed ID: 10983282
[TBL] [Abstract][Full Text] [Related]
57. [Studies on the synthesis of cholecystokinin A receptor antagonists. I. synthesis and cholecystokinin A receptor inhibitory activities of malonamide derivatives].
Ajisawa Y; Kitazawa M; Uchida M; Kobayashi M
Yakugaku Zasshi; 1996 Jan; 116(1):50-8. PubMed ID: 8699319
[TBL] [Abstract][Full Text] [Related]
58. "Dipeptoids": from the chemical structure of the endogenous peptide to the design of peptidomimetics.
Martín-Martínez M; Patiño-Molina R; García-López MT; González-Muñiz R
Mini Rev Med Chem; 2004 Aug; 4(6):669-80. PubMed ID: 15279601
[TBL] [Abstract][Full Text] [Related]
59. Partitioning psychological and physical sources of transport-related stress in young cattle.
Jacobson LH; Cook CJ
Vet J; 1998 Mar; 155(2):205-8. PubMed ID: 9564276
[No Abstract] [Full Text] [Related]
60. [Optimization of the synthesis of indolyl-2-thioether from derivatives of tryptophane and cysteine].
Wieland T; Jochum C; Faulstich H
Justus Liebigs Ann Chem; 1969; 727():138-42. PubMed ID: 5823708
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
